Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $34.2000 (3.95%) ($32.5000 - $34.6400) on Fri. Oct. 14, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.81% (three month average) | RSI | 56 | Latest Price | $34.2000(3.95%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR advances 0.4% a day on average for past five trading days. | Weekly Trend | CAPR advances 2.1% a week on average for past two weeks. | Market Behavior | Normal for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) SKYY(8%) PEJ(7%) VT(7%) XLF(7%) ARKK(6%) | Factors Impacting CAPR price | CAPR will decline at least -1.905% in a week (0% probabilities). TLT(-6%) IPO(-6%) VIXM(-5%) GLD(-5%) GDX(-5%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.905% (StdDev 3.81%) | Hourly BBV | 0 () | Intraday Trend | 2.4% | | | |
|
5 Day Moving Average | $34.02(0.53%) | 10 Day Moving Average | $33.66(1.6%) | 20 Day Moving Average | $34.03(0.5%) | To recent high | -19.9% | To recent low | 8.2% | Market Cap | $674m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |